{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:01:47Z","timestamp":1789848107013,"version":"4.0.1"},"reference-count":13,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objective.<\/jats:bold>\n                    This study was aimed to develop a mathematical model for predicting the presence of pathological alleles of the angiotensin II receptor type 1 (AGTR1) (C1166C) and endothelial nitric oxide synthase (eNOS) (T786C) genes in patients with arterial hypertension using readily available clinical and demographic parameters without the need for laboratory genetic analysis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods.<\/jats:bold>\n                    The study included 86 patients with arterial hypertension, 45 of whom had also clinical signs of ischemic heart disease and 30 healthy controls. Clinical and demographic data, including age, sex, body mass index (BMI), smoking and alcohol habits, and systolic and diastolic blood pressure, were collected. A predictive model of genetic polymorphism was constructed using a multivariate regression analysis in Statistica 10.0. Model quality was assessed via residual analysis (histogram, normal probability plot, scatter plot), ANOVA, and the Nagelkerke coefficient of determination (R\u00b2).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.<\/jats:bold>\n                    Eight significant predictors of pathological gene variants were identified: age, sex, disease duration, BMI, smoking, alcohol consumption, systolic blood pressure, and diastolic blood pressure. The regression model explained 98.42% of the variance in gene polymorphism (R\u00b2=0.9842). Residuals were normally distributed and randomly scattered confirming the model adequacy. ANOVA analysis demonstrated high statistical significance (p&lt;0.001) indicating that the model performed significantly better than predictions based on the mean values. The model allows inference of the probable presence of C alleles in AGTR1 and eNOS genes using simple clinical information.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions.<\/jats:bold>\n                    The proposed mathematical model demonstrates high predictive capability and statistical stability providing a cost-effective tool for preliminary genetic screening in patients with hypertension. It enables identification of individuals at risk for carrying pathological gene variants and supports the implementation of a personalized approach in clinical practice. Further validation on independent datasets is recommended.\n                  <\/jats:p>","DOI":"10.2478\/enr-2026-0024","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:09:11Z","timestamp":1789844951000},"page":"231-236","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of genetic polymorphisms in patients with arterial hypertension and ischemic heart disease"],"prefix":"10.2478","volume":"60","author":[{"given":"Svitlana","family":"Pidruchna","sequence":"first","affiliation":[{"name":"1 Department of Medical Biochemistry , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadiya","family":"Yarema","sequence":"additional","affiliation":[{"name":"2 Department of Internal Medicine \u21161 , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Kuzmak","sequence":"additional","affiliation":[{"name":"1 Department of Medical Biochemistry , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Prokopovych","sequence":"additional","affiliation":[{"name":"3 Emergency Medical Care , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Kotsiuba","sequence":"additional","affiliation":[{"name":"4 Therapeutics and Family Medicine , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrii","family":"Sverstuk","sequence":"additional","affiliation":[{"name":"5 Department of Medical Informatics , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Bahrii-Zaiats","sequence":"additional","affiliation":[{"name":"6 Department of Medical Physics of Diagnostic and Therapeutic Equipment , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petro","family":"Lykhatskyi","sequence":"additional","affiliation":[{"name":"1 Department of Medical Biochemistry , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Mudra","sequence":"additional","affiliation":[{"name":"1 Department of Medical Biochemistry , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lylya","family":"Palytsya","sequence":"additional","affiliation":[{"name":"1 Department of Medical Biochemistry , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Letniak","sequence":"additional","affiliation":[{"name":"1 Department of Medical Biochemistry , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Ostrivka","sequence":"additional","affiliation":[{"name":"1 Department of Medical Biochemistry , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetyana","family":"Yaroshenko","sequence":"additional","affiliation":[{"name":"1 Department of Medical Biochemistry , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadija","family":"Vasylyshyn","sequence":"additional","affiliation":[{"name":"1 Department of Medical Biochemistry , I. Horbachevsky Ternopil National Medical University , Ternopil , Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"2026091919090749331_j_enr-2026-0024_ref_001","doi-asserted-by":"crossref","unstructured":"Abu-El-Haija A, Reddi HV, Wand H, Rose NC, Mori M, Qian E, Murray MF; ACMG Professional Practice and Guidelines Committee. Electronic address: documents@acmg.net. The clinical application of polygenic risk scores: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 25, 100803, 2023.","DOI":"10.1016\/j.gim.2023.100803"},{"key":"2026091919090749331_j_enr-2026-0024_ref_002","doi-asserted-by":"crossref","unstructured":"Choi SW, Mak TSH, O\u2019Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc 15, 2759\u20132772, 2020.","DOI":"10.1038\/s41596-020-0353-1"},{"key":"2026091919090749331_j_enr-2026-0024_ref_003","doi-asserted-by":"crossref","unstructured":"Padmanabhan S, du Toit C, Dominiczak AF. Genetics of hypertension and heart failure. In: Hypertension and Heart Failure: Epidemiology, Mechanisms and Treatment (Eds. Dorobantu M, Voicu V, Grassi G, Agabiti-Rosei E, Mancia G), pp. 37\u201251, Springer, Cham, 2024.","DOI":"10.1007\/978-3-031-39315-0_4"},{"key":"2026091919090749331_j_enr-2026-0024_ref_004","doi-asserted-by":"crossref","unstructured":"Pidruchna S, Shmanko V, Hnizdyukh R, Sverstiuk A, Lykhatskyy P, Kuzmak I, Yaroshenko T, Bandas I, Vasylyshyn N, Ostrivka O, Mudra A, Palytsia L, Letnyak N, Tokarskyy O. Statistically verified methods for determining predictors of development of arterial hypertension depending on endothelial nitric oxide synthase T786C gene promoter polymorphism using lipid profile indicators. Endocr Regul 58, 138\u2013143, 2024a.","DOI":"10.2478\/enr-2024-0015"},{"key":"2026091919090749331_j_enr-2026-0024_ref_005","doi-asserted-by":"crossref","unstructured":"Pidruchna S, Shmanko V, Zakharchuk U, Tokarskyy O, Hnizdyukh R, Lynkhatskyi P, Kuzmak I, Yaroshenko T, Bandas I, Vasylyshyn N, Ostrivka O, Mudra A, Palytsya L, Letniak N, Pohorielova O. Changes in adipokine indicators depending on A1166C polymorphism of the angiotensin II type 1 receptor gene as a predictor of the arterial hypertension. Endocr Regul 58, 153\u2013157, 2024b.","DOI":"10.2478\/enr-2024-0017"},{"key":"2026091919090749331_j_enr-2026-0024_ref_006","doi-asserted-by":"crossref","unstructured":"Potaskalova VS, Khaitovych NV, Natrus LV, Abdriakhimova TB, Lunov VY, Kleban KI, Korop OA. The effect of NOS3 and AGTR1 genotypes on the course of the arterial hypertension for owerweight or obese patients. Wiad Lek 75, 533\u2013540, 2022.","DOI":"10.36740\/WLek202202137"},{"key":"2026091919090749331_j_enr-2026-0024_ref_007","doi-asserted-by":"crossref","unstructured":"Shmanko VV, Pidruchna SR, Hnizdyukh RV, Mudra AE, Zakharchuk UM, Kuzmak IP, Yaroshenko TY, Palytsya LM, Bandas IA, Dzhyvak VH, Nikitina IM, Zavarynska IF. Changes in lipid profile parameters depending on the a1166c polymorphism of the angiotensin II type I receptor gene as a predictor of arterial hypertension. Wiad Lek 77, 1554\u20131561, 2024.","DOI":"10.36740\/WLek202408104"},{"key":"2026091919090749331_j_enr-2026-0024_ref_008","doi-asserted-by":"crossref","unstructured":"Tran DC, Le LHG, Thai TT, Van Hoang S, Do MD, Truong BQ. Effect of AGTR1 A1166C genetic polymorphism on coronary artery lesions and mortality in patients with acute myocardial infarction. PloS One 19, e0300273, 2024.","DOI":"10.1371\/journal.pone.0300273"},{"key":"2026091919090749331_j_enr-2026-0024_ref_009","doi-asserted-by":"crossref","unstructured":"Vaura F, Kauko A, Suvila K, Havulinna AS, Mars N, Salomaa V, Cheng FGS, Niiranen T. Polygenic risk scores predict hypertension onset and cardiovascular risk. Hypertension 77, 1119\u20131127, 2021.","DOI":"10.1161\/HYPERTENSIONAHA.120.16471"},{"key":"2026091919090749331_j_enr-2026-0024_ref_010","doi-asserted-by":"crossref","unstructured":"Wang Y, Wang JG. Genome-wide association studies of hypertension and several other cardiovascular diseases. Pulse 6, 169\u2013186, 2019.","DOI":"10.1159\/000496150"},{"key":"2026091919090749331_j_enr-2026-0024_ref_011","unstructured":"Warren HR, Evangelou E, Cabrera CP, Gao H, Ren M, Mifsud B et al. Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet 49, 403\u2013415, 2017."},{"key":"2026091919090749331_j_enr-2026-0024_ref_012","doi-asserted-by":"crossref","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement D, Coca A, De Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen S, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder R, Shlyakhto E, Tsioufis K, Aboyans V, Desormais I; List of authors\/Task Force members:. 2018 Practice Guidelines for the Management of Arterial Hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH\/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 36, 2284\u20132309, 2018.","DOI":"10.1097\/HJH.0000000000001961"},{"key":"2026091919090749331_j_enr-2026-0024_ref_013","unstructured":"Yarema N, Kotsiuba O, Krytskyy T, Marushchak M, Krynytska I. Peculiarities of arterial hypertension in postmenopausal women with bone mineral density disorders and dyslipidemia. Pol Merkur Lekarski 48, 5\u20139, 2020."}],"container-title":["Endocrine Regulations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/enr-2026-0024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:09:14Z","timestamp":1789844954000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/enr-2026-0024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,9,19]]},"published-print":{"date-parts":[[2026,1,1]]}},"alternative-id":["10.2478\/enr-2026-0024"],"URL":"https:\/\/doi.org\/10.2478\/enr-2026-0024","relation":{},"ISSN":["1336-0329"],"issn-type":[{"value":"1336-0329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]}}}